載入中
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
最新資料
US$27.93
+US$0.10 · +0.36%
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 12.89億 USD | 11.67億 USD | 10.89億 USD | 7.87億 USD | 5.01億 USD |
| 銷貨成本 | 9.84億 USD | 9.14億 USD | 8.5億 USD | 6.2億 USD | 3.88億 USD |
| 毛利 | 3.04億 USD | 2.53億 USD | 2.39億 USD | 1.67億 USD | 1.12億 USD |
| 銷售、一般及管理費用 | 2.19億 USD | 1.86億 USD | 1.77億 USD | 1.44億 USD | 7979.5萬 USD |
| 營業費用 | 2.19億 USD | 1.86億 USD | 1.77億 USD | 1.44億 USD | 7979.5萬 USD |
| 利息收入 | 1015.5萬 USD | 1574.7萬 USD | 850.7萬 USD | 81.4萬 USD | 46.1萬 USD |
| 折舊和攤銷 | 494.8萬 USD | 317.5萬 USD | 228.1萬 USD | 160.1萬 USD | 130.1萬 USD |
| 營業利益 | 8527.7萬 USD | 6745.5萬 USD | 6218.4萬 USD | 2334.1萬 USD | 3234萬 USD |
| 淨利 | 5852萬 USD | 5433.6萬 USD | 6203.7萬 USD | 3035.8萬 USD | 6576.9萬 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$35.50
上漲空間 27.10%價格歷史記錄不可用
最高：US$40.00平均的：US$35.50最低：US$30.00AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
